{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T23:20:37Z","timestamp":1649200837503},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologie Biologie"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.patbio.2012.04.002","type":"journal-article","created":{"date-parts":[[2012,5,25]],"date-time":"2012-05-25T11:02:28Z","timestamp":1337943748000},"page":"392-398","source":"Crossref","is-referenced-by-count":0,"title":["La communication intercellulaire par l\u2019interm\u00e9diaire des jonctions gap\u00a0: un nouveau m\u00e9canisme dans la physiopathologie de la migraine avec aura. Applications th\u00e9rapeutiques"],"prefix":"10.1016","volume":"60","author":[{"given":"D.","family":"Sarrouilhe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dejean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.patbio.2012.04.002_bib0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1474-4422(06)70348-9","article-title":"Chronic disorders with episodic manifestations: focus on epilepsy and migraine","volume":"5","author":"Haut","year":"2006","journal-title":"Lancet Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.patbio.2012.04.002_bib0010","first-page":"9","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain","volume":"24","author":"Headache Classification Committee of the International Headache Society","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.patbio.2012.04.002_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/medicina46010001","article-title":"Diversity and properties of connexin gap junction channels","volume":"63","author":"Rackauskas","year":"2010","journal-title":"Medicina"},{"key":"10.1016\/j.patbio.2012.04.002_bib0020","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.patbio.2008.05.009","article-title":"Connexins and junctional channels. Roles in the spreading of cardiac electrical excitation and heart development","volume":"56","author":"Herv\u00e9","year":"2008","journal-title":"Pathol Biol"},{"key":"10.1016\/j.patbio.2012.04.002_bib0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00756491","article-title":"Cell culture assays for chemicals with tumor-promoting or tumor-inhibiting activity based on the modulation of intercellular communication","volume":"10","author":"Budunova","year":"1994","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.patbio.2012.04.002_bib0030","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2174\/1381612054021060","article-title":"Connexin-made channels as pharmacological targets","volume":"11","author":"Herv\u00e9","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.patbio.2012.04.002_bib0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbamem.2004.01.009","article-title":"Gap junctions and neurological disorders of the central nervous system","volume":"1662","author":"Nakase","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.patbio.2012.04.002_bib0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12031-007-9027-5","article-title":"Gap junctions couple astrocytes and oligodendrocytes","volume":"35","author":"Orthmann-Murphy","year":"2007","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.patbio.2012.04.002_bib0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4161\/chan.2.2.6003","article-title":"Connexin and pannexin hemichannels of neurons and astrocytes","volume":"2","author":"Thompson","year":"2008","journal-title":"Channels"},{"key":"10.1016\/j.patbio.2012.04.002_bib0050","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00424-010-0789-1","article-title":"Gap junctions in inherited human disease","volume":"460","author":"Zoidl","year":"2010","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.patbio.2012.04.002_bib0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0248-4900(02)00016-3","article-title":"Gap junctions and connexin expression in the normal and pathological central nervous system","volume":"94","author":"Rouach","year":"2002","journal-title":"Biol Cell"},{"key":"10.1016\/j.patbio.2012.04.002_bib0060","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/jcp.2008.055699","article-title":"Clinical connexions","volume":"61","author":"Alldredge","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.patbio.2012.04.002_bib0065","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1474-4422(09)70090-0","article-title":"Origin of pain in migraine: evidence for peripheral sensitisation","volume":"8","author":"Olesen","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.patbio.2012.04.002_bib0070","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neuroscience.2009.03.019","article-title":"Neurobiology of migraine","volume":"161","author":"Goadsby","year":"2009","journal-title":"Neurosci"},{"key":"10.1016\/j.patbio.2012.04.002_bib0075","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nm0202-136","article-title":"Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model","volume":"8","author":"Bolay","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.patbio.2012.04.002_bib0080","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ng.856","article-title":"Genome-wide association study reveals three susceptibility loci for common migraine in the general population","volume":"43","author":"Chasman","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.patbio.2012.04.002_bib0085","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ng.652","article-title":"Genome-wide association study of migraine implicates a common susceptibility variant on 8q221.1","volume":"42","author":"Antilla","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.patbio.2012.04.002_bib0090","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.mehy.2009.10.027","article-title":"How triggers trigger acute migraine attacks: a hypothesis","volume":"74","author":"Chakravarty","year":"2010","journal-title":"Med Hypothesis"},{"issue":"Suppl. 1","key":"10.1016\/j.patbio.2012.04.002_bib0095","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1007\/s10072-011-0529-0","article-title":"Migraine with aura: conventional and non conventional treatments","volume":"32","author":"D\u2019Andrea","year":"2011","journal-title":"Neurol Sci"},{"key":"10.1016\/j.patbio.2012.04.002_bib0100","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1526-4610.2009.01429.x","article-title":"Revisiting the efficacy of sumatriptan therapy during the aura phase of migraine","volume":"49","author":"Aurora","year":"2009","journal-title":"Headache"},{"key":"10.1016\/j.patbio.2012.04.002_bib0105","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(10)60323-6","article-title":"New drugs in migraine treatment and propylaxis: telcagepant and topiramate","volume":"376","author":"Edvinsson","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.patbio.2012.04.002_bib0110","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1468-1331.2009.02748.x","article-title":"EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force","volume":"16","author":"Evers","year":"2009","journal-title":"Eur J Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.patbio.2012.04.002_bib0115","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1007\/s10072-011-0526-3","article-title":"Migraine prophylaxis: what is new and what we need?","volume":"32","author":"Barbanti","year":"2011","journal-title":"Neurol Sci"},{"key":"10.1016\/j.patbio.2012.04.002_bib0120","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.tips.2011.02.016","article-title":"Emerging migraine treatments and drug targets","volume":"32","author":"Olesen","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.patbio.2012.04.002_bib0125","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neulet.2011.11.031","article-title":"Amitriptyline calcium currents and intracellular calcium concentration in mouse trigeminal ganglion neurons","volume":"506","author":"Wu","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.patbio.2012.04.002_bib0130","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/jnnp.2005.063750","article-title":"Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura","volume":"76","author":"Lampl","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.patbio.2012.04.002_bib0135","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1212\/WNL.0b013e31820c95cc","article-title":"Current understanding and treatment of headache disorders: five new things","volume":"76","author":"Marmura","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.patbio.2012.04.002_bib0140","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1517\/13543784.2011.601741","article-title":"Migraine prophylactic drugs \u2013 something new under the sun","volume":"20","author":"Bekkelund","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.patbio.2012.04.002_bib0145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0960-894X(98)00728-8","article-title":"Identification of (-)-cis-6-acetyl-4S\u2013(3-chloro-4-fluoro-benzoylamino)-3,4-dihydro-2,2-dimethyl-2H-benzo[b] pyran-3S-ol as a potential antimigraine agent","volume":"9","author":"Chan","year":"1999","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.patbio.2012.04.002_bib0150","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1468-2982.2000.00022.x","article-title":"S.B-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized cat","volume":"20","author":"Read","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/j.patbio.2012.04.002_bib0155","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1468-2982.2000.00092.x","article-title":"Repetitive cortical spreading depression in a gyrencephalic feline brain: inhibition by the novel benzoylamino-benzopyran SB-220453","volume":"20","author":"Smith","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/j.patbio.2012.04.002_bib0160","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1468-2982.2000.00078.x","article-title":"The potential antimigraine compound SB-220453\u00a0does not contract human isolated blood vessels or myocardium; a comparison with sumatriptan","volume":"20","author":"MaassenVanDenBrink","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/j.patbio.2012.04.002_bib0165","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/sj.bjp.0703932","article-title":"Tonabersat (SB-220453) a novel benzopyran with anticonvulsivant properties attenuates trigeminal nerve-induced neurovascular reflexes","volume":"132","author":"Parsons","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.patbio.2012.04.002_bib0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1526-4610.2008.01262.x","article-title":"Tonabersat inhibits trigeminal ganglion neuronal-satellite glial cell signaling","volume":"49","author":"Damodaram","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.patbio.2012.04.002_bib0175","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1468-2982.2004.00762.x","article-title":"A double-blind study of SB-220453 (tonabersat) in the glyceryltrinitrate (GTN) model of migraine","volume":"24","author":"Tvedskov","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.patbio.2012.04.002_bib0180","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1468-2982.2008.01804.x","article-title":"Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis","volume":"29","author":"Goadsby","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/j.patbio.2012.04.002_bib0185","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1474-4422(09)70135-8","article-title":"Effects of tonabersat on migraine with aura: a randomized, double-blind, placebo-controlled crossover study","volume":"8","author":"Hauge","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.patbio.2012.04.002_bib0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1468-2982.2009.01975.x","article-title":"Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study","volume":"29","author":"Dahl\u00f6f","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/j.patbio.2012.04.002_bib0195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-2982.2009.01974.x","article-title":"Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine","volume":"29","author":"Silberstein","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/j.patbio.2012.04.002_bib0200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1468-2982.2009.01973.x","article-title":"Tonabersat, a novel gap-junction modulator for the prevention of migraine","volume":"29","author":"Silberstein","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/j.patbio.2012.04.002_bib0205","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1474-4422(11)70266-6","article-title":"Migraine and stroke: a complex association with clinical implications","volume":"11","author":"Kurth","year":"2012","journal-title":"Lancet Neurol"}],"container-title":["Pathologie Biologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811412000491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811412000491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T03:41:30Z","timestamp":1561779690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0369811412000491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0369811412000491"],"URL":"https:\/\/doi.org\/10.1016\/j.patbio.2012.04.002","relation":{},"ISSN":["0369-8114"],"issn-type":[{"value":"0369-8114","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}